Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. - Han,S.H.; Martin,P.; Edelstein,M.; Hu,R.; Kunder,G.; Holt,C.; Saab,S.; Durazo,F.; Goldstein,L.; Farmer,D.; Ghobrial,R.M.; Busuttil,R.W. (Liver Transpl, 2003)